All for Joomla
All for Webmasters
Hemostasis
Acute Care Diagnostics
Autoimmunity
Transfusion
Transplant
#GiveToGain
WTDay
Cyber Health
EEMEA Learning Center - risk
D-Dimer. Risk of Recerrent VTE and Optimal Duration of Antithrombotic Prophylaxis
Read more...
The urgent need to implement patient blood management: policy brief
Read more...
Factor XIII levels, clot strength, and impact of fibrinogen concentrate in infants undergoing cardiopulmonary bypass: a mechanistic sub-study of the FIBCON trial
Read more...
High on-treatment platelet reactivity is associated with poor outcomes after ischemic stroke: A meta-analysis
Read more...
Risk Assessment for VTE in Cancer
Read more...
Hemostasis in Coronavirus Disease 2019-Lesson from Viscoelastic Methods: A Systematic Review
Read more...
Rotational Thromboelastometry Reveals Distinct Coagulation Profiles for Patients With COVID-19 Depending on Disease Severity
Read more...
Dynamic Hemostasis and Fibrinolysis Assays in Intensive Care COVID-19 Patients and Association with Thrombosis and Bleeding-A Systematic Review and a Cohort Study
Read more...
The Procoagulant Effect of COVID-19 on the Thrombotic Risk of Patients with Hip Fractures Due to Enhanced Clot Strength and Fibrinolysis Shutdown
Read more...
Hemostasis in Coronavirus Disease 2019-Lesson from Viscoelastic Methods: A Systematic Review
Read more...
Questions about COVID-19 associated coagulopathy: possible answers from the viscoelastic tests
Read more...
Trimester-specific thromboelastic values and coagulation activation markers in pregnancy compared across trimesters and compared to the nonpregnant state
Read more...
How Can Rotational Thromboelastometry as a Point-of-Care Method Be Useful for the Management of Secondary Thromboprophylaxis in High-Risk Pregnant Patients?
Read more...
Reduction in massive postpartum haemorrhage and red blood cell transfusion during a national quality improvement project, Obstetric Bleeding Strategy for Wales, OBS Cymru: an observational study
Read more...
Clinical impact of rotational thromboelastometry in cardiac surgery
Read more...
Clinical Validation of a Novel Quality Management System for Blood Gas, Electrolytes, Metabolites, and CO-Oximetry
Read more...
Reduction of thromboembolic complications during the endovascular treatment of unruptured aneurysms by employing a tailored dual antiplatelet regimen using aspirin and prasugrel
Read more...
Long-term complications after stent assist coiling dependent on clopidogrel response
Read more...
The inhibition rate estimated using VerifyNow can help to predict the thromboembolic risk of coil embolization for unruptured intracranial aneurysms
Read more...
High On-Treatment Platelet Reactivity as Predictor of Long-term Clinical Outcomes in Stroke Patients with Antiplatelet Agents
Read more...
Clopidogrel Resistance in Patients With Stroke Recurrence Under Single or Dual Antiplatelet Treatment
Read more...
D3 - Session 5 - D-Dimer and Arterial Diseases
Read more...
D3 - Session 4 - D-Dimer in Cancer and VTE
Read more...
D3 - Session 3 - Analytical Aspects of D-Dimer Assays
Read more...
D3 - Session 2 - General Overview of Fibrinolysis
Read more...
D3 - Session 1 - Covid19 Associated Coagulopathies: A Year in Review
Read more...
Variability in initial response to standard clopidogrel therapy, delayed conversion to clopidogrel hyper-response, and associated thromboembolic and hemorrhagic complications in patients undergoing endovascular treatment of unruptured cerebral aneury
Read more...
Thromboembolic complications with Pipeline Embolization Device placement: impact of procedure time, number of stents and pre-procedure P2Y12 reaction unit (PRU) value
Read more...
Efficacy of a two-test protocol for achieving a therapeutic response to clopidogrel prior to elective endovascular intracranial aneurysm treatment and an 'induced' postoperative hyper-response
Read more...
Use of Platelet Function Testing Before Pipeline Embolization Device Placement: A Multicenter Cohort Study
Read more...
Predictive value of platelet reactivity unit (PRU) value for thrombotic and hemorrhagic events during flow diversion procedures: a meta-analysis
Read more...
Ticagrelor Is Superior to Clopidogrel in Inhibiting Platelet Reactivity in Patients With Minor Stroke or TIA
Read more...
Association between CYP2C9 polymorphisms and ischemic stroke following endovascular neurointervention
Read more...
Risk Factor Analysis of Delayed Intracerebral Hemorrhage After Coil Embolization of Unruptured Cerebral Aneurysms
Read more...
Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: First update 2016
Read more...
Management of antiplatelet therapy for non-elective invasive procedures or bleeding complications: Proposals from the French Working Group on Perioperative Haemostasis (GIHP) and the French Study Group on Thrombosis and Haemostasis (GFHT), in collabo
Read more...
Percutaneous Coronary Intervention With an Initial Bolus of Low-Dose Heparin in Biomarker-Negative Patients
Read more...
Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial
Read more...
Platelet activity measured by a rapid turnaround assay identifies coronary artery bypass grafting patients at increased risk for bleeding and transfusion complications after clopidogrel administration
Read more...
Safety and efficacy of cangrelor, an intravenous, short-acting platelet inhibitor in patients requiring coronary artery bypass surgery
Read more...
Elevated plasma fibrinogen rather than residual platelet reactivity after clopidogrel pre-treatment is associated with an increased ischemic risk during elective percutaneous coronary intervention
Read more...
Efficacy and safety of intensified antiplatelet therapy on the basis of platelet reactivity testing in patients after percutaneous coronary intervention: systematic review and meta-analysis
Read more...
Posttreatment platelet reactivity on clopidogrel is associated with the risk of adverse events after off-pump coronary artery bypass
Read more...
How do we manage cardiopulmonary bypass coagulopathy?
Read more...
Aspirin unresponsiveness predicts thrombosis in high-risk pediatric patients after cardiac surgery
Read more...
Utility of VerifyNow for Point-of-Care Identification of an Aspirin Effect Prior to Emergency Cardiac Surgery
Read more...
Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention
Read more...
Platelet Reactivity Unit in Predicting Risk of Bleeding in Patients Undergoing Coronary Artery Bypass Graft Surgery
Read more...
Assessment of Bleeding and Thrombosis Based on Aspirin Responsiveness after Continuous-Flow Left Ventricular Assist Device Placement
Read more...
The effect of correcting VerifyNow P2Y12 assay results for hematocrit in patients undergoing percutaneous coronary interventions
Read more...
Is There a Role for Preoperative Platelet Function Testing in Patients Undergoing Cardiac Surgery During Antiplatelet Therapy?
Read more...
Platelet Activity Measured by VerifyNow® Aspirin Sensitivity Test Identifies Coronary Artery Bypass Surgery Patients at Increased Risk for Postoperative Bleeding and Transfusion
Read more...
Assessment of platelet function after discontinuation of ticagrelor
Read more...
Impact of Routine Platelet Reactivity Testing with VerifyNow Assay on Antiplatelet Choice After Percutaneous Coronary Intervention
Read more...
Increased platelet inhibition after switching from prasugrel to low-dose ticagrelor in Japanese patients with prior myocardial infarction
Read more...
Evening aspirin intake results in higher levels of platelet inhibition and a reduction in reticulated platelets - a window of opportunity for patients with cardiovascular disease?
Read more...
Open-label multicenter registry on the outcomes of peripheral arterial disease treated by balloon angioplasty with optical frequency domain imaging in superficial femoral artery and popliteal artery (OCEAN-SFA study)
Read more...
Validation of the ABCD-GENE score to identify high platelet reactivity in east Asian patients undergoing percutaneous coronary intervention
Read more...
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the Euro
Read more...
Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y 12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention
Read more...
High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients
Read more...
D-Dimer and Prothrombin Time Are the Significant Indicators of Severe COVID-19 and Poor Prognosis
Read more...
Early coagulation tests predict risk stratification and prognosis of COVID-19
Read more...
Coagulopathy in COVID-19: Posted april 24, 2020
Read more...
Coagulopathy in COVID-19 and Its Implication for Safe and Efficacious Thromboprophylaxis
Read more...
Chronic therapeutic anticoagulation is associated with decreased thrombotic complications in SARS-CoV-2 infection
Read more...
Heparin induced thrombocytopenia antibodies in Covid‐19
Read more...
Incidence of thrombosis and hemorrhage in hospitalized cancer patients with COVID‐19
Read more...
Coagulopathy and Thrombosis as a Result of Severe COVID-19 Infection: A Microvascular Focus
Read more...
Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility
Read more...
Coagulation biomarkers are independent predictors of increased oxygen requirements in COVID-19
Read more...
Prevalence of Venous Thromboembolism in Critically Ill COVID-19 Patients: Systematic Review and Meta-Analysis
Read more...
Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis
Read more...
Thromboprophylaxis in a patient with COVID-19 and severe hemophilia A on emicizumab prophylaxis
Read more...
COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options
Read more...
Clinical Characteristics of Coronavirus Disease 2019 in China
Read more...
Current Perspectives of Anticoagulation in Patients With COVID-19
Read more...
COVID-19 Related Arterial Coagulopathy
Read more...
Macrothrombosis and stroke in patients with mild Covid‐19 infection
Read more...
Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19
Read more...
Clotting Factors in COVID-19: Epidemiological Association and Prognostic Values in Different Clinical Presentations in an Italian Cohort
Read more...
Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia
Read more...
Hematological findings and complications of COVID-19
Read more...
ISTH interim guidance on recognition and management of coagulopathy in COVID-19
Read more...
COVID-19: a probable role of the anticoagulant Protein S in managing COVID-19-associated coagulopathy
Read more...
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Read more...
COVID-19 and acute coagulopathy in pregnancy
Read more...
Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
Read more...
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study
Read more...
Response to "All these D-dimers in COVID-19"
Read more...
Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology
Read more...
Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia
Read more...
Heparin resistance in COVID-19 patients in the intensive care unit
Read more...
Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors
Read more...
In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID-19 patients on anticoagulation
Read more...
Evaluation of COVID-19 coagulopathy; laboratory characterization using thrombin generation and nonconventional haemostasis assays
Read more...
Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis
Read more...
COVID-19-Related Aortic Thrombosis: A Report of Four Cases
Read more...
COVID-19 hypothesis: Activated protein C for therapy of virus-induced pathologic thromboinflammation
Read more...
Start
Prev
1
2
Next
End
Page 1 of 2
Werfen.com.
All rights Reserved.
Privacy Policy
|
Cookies Policy
|
Terms of Service
No Internet Connection